Partner

Shanghai

+86 21 6061 3599

Highly regarded

Chinese & English


Bar admissions:

China

Jurisdictions:

China

Practice areas:

Investment funds


  • Advised Curon Biopharmaceutical on its US$150 million Series A financing, led by 6 Dimensions, Temasek and Boyu
  • Advised IDG on the formation of semiconductor and AI merger fund (Yiwu Jinhong Fund). This fund has raised RMB10.8 billion and is still in the process of fundraising.
  • Advised client during the whole process of the formation of the Beijing Fund (the “Fund”) jointly established by Tishman Speyer and Shougang Fund. Matter value is about RMB1.8 billion
  • Advised Lilly Asia Ventures on the merger of its portpolios, Hangzhou Just Biotherapeutics and MabSpace Biosciences to create Transcenta Holding Ltd., a world-class biotherapeutics company.

  • Investment funds
  • Private equity

  • Financial services
  • Healthcare
  • Investment management
  • Pharma and life sciences

  • PRC Admitted Lawyer

  • Secretary General, CEIBS Alumni PE Association Shanghai 
  • Member, Shanghai Bar Association Fund Research Committee 
  • Mediator, Shanghai Pudong Professional Mediation Center 
  • Co-chair, Fund Asset Backed Securitization Committee of China Asset Backed Securitization Forum

  • LL.M. (East China Univ. of Political Science and Law) 
  • LL.B. (East China Univ. of Political Science and Law)
  • EMBA (China Europe International Business School)